Sun Pharma Acquires Organon in $11.75 Billion Deal
Sun Pharmaceuticals has agreed to acquire Organon & Co for $11.75 billion in an all-cash deal, marking the largest overseas acquisition by an Indian pharmaceutical company. The acquisition will expand Sun Pharma's presence in developed markets and diversify its portfolio beyond generics. The deal is expected to close in early 2027.
Topics: acquisition global expansion mergers and acquisitions pharmaceutical industry stock market